2023 ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the …
2023 ESC Guidelines for the management of acute coronary syndromes Page 1 2023 ESC
Guidelines for the management of acute coronary syndromes Developed by the task force on …
Guidelines for the management of acute coronary syndromes Developed by the task force on …
Common Pathophysiology in Cancer, Atrial Fibrillation, Atherosclerosis, and Thrombosis: JACC: CardioOncology State-of-the-Art Review
Cardiovascular disease and cancer are the 2 leading causes of death worldwide. Emerging
evidence suggests common mechanisms between cancer and cardiovascular disease …
evidence suggests common mechanisms between cancer and cardiovascular disease …
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic …
AR Lyon, T Lopez-Fernandez, LS Couch… - European Heart …, 2022 - academic.oup.com
ESC Guidelines e341 (1) the specific situation of the patient. In this respect, it is specified
that, unless otherwise provided for by national regulations, offlabel use of medication should …
that, unless otherwise provided for by national regulations, offlabel use of medication should …
Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Consensus Document of the Acute CardioVascular Care (ACVC) …
SA Gevaert, S Halvorsen, PR Sinnaeve… - … Heart Journal Acute …, 2021 - academic.oup.com
Advances in treatment, common cardiovascular (CV) risk factors and the ageing of the
population have led to an increasing number of cancer patients presenting with acute CV …
population have led to an increasing number of cancer patients presenting with acute CV …
[HTML][HTML] Treatment strategies of acute myocardial infarction: updates on revascularization, pharmacological therapy, and beyond
Y Saito, K Oyama, K Tsujita, S Yasuda, Y Kobayashi - Journal of cardiology, 2023 - Elsevier
Owing to recent advances in early reperfusion strategies, pharmacological therapy,
standardized care, and the identification of vulnerable patient subsets, the prognosis of …
standardized care, and the identification of vulnerable patient subsets, the prognosis of …
[HTML][HTML] Cardio-oncology: a myriad of relationships between cardiovascular disease and cancer
Y Wang, Y Wang, X Han, J Sun, C Li… - Frontiers in …, 2022 - frontiersin.org
Cardiovascular disease (CVD) and cancer are the leading causes of death worldwide. With
an increasing number of the elderly population, and early cancer screening and treatment …
an increasing number of the elderly population, and early cancer screening and treatment …
Cardiac Computed Tomography in Cardio-Oncology: JACC: CardioOncology Primer
Cancer patients and survivors have elevated cardiovascular risk when compared with
noncancer patients. Cardio-oncology has emerged as a new subspecialty to comanage and …
noncancer patients. Cardio-oncology has emerged as a new subspecialty to comanage and …
Effect of primary percutaneous coronary intervention on in-hospital outcomes among active cancer patients presenting with ST-elevation myocardial infarction: a …
MO Mohamed, HGC Van Spall… - … Heart Journal Acute …, 2021 - academic.oup.com
Aims Primary percutaneous coronary intervention (pPCI) is the gold standard, guideline-
recommended revascularization strategy in patients presenting with ST-elevation …
recommended revascularization strategy in patients presenting with ST-elevation …
Venous and arterial thromboembolism in patients with cancer treated with targeted anti-cancer therapies
Patients with cancer have an increased risk of venous-and arterial thromboembolism
(VTE/ATE). Anti-cancer treatments including surgery, radiotherapy, and certain …
(VTE/ATE). Anti-cancer treatments including surgery, radiotherapy, and certain …
Patient mortality following new‐onset heart failure stratified by cancer type and status
N Nouhravesh, JE Strange, A Holt… - European Journal of …, 2023 - Wiley Online Library
Aim Expected 1‐year survival is essential to risk stratification of patients with heart failure
(HF); however, little is known about the 1‐year prognosis of patients with HF and cancer …
(HF); however, little is known about the 1‐year prognosis of patients with HF and cancer …